Literature DB >> 17158882

The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription.

Delphine Cougot1, Yuanfei Wu1, Stefano Cairo1, Julie Caramel1, Claire-Angélique Renard1, Laurence Lévy1, Marie Annick Buendia1, Christine Neuveut2.   

Abstract

The hepatitis B virus infects more than 350 million people worldwide and is a leading cause of liver cancer. The virus encodes a multifunctional regulator, the hepatitis B virus X protein (HBx), that is essential for virus replication. HBx is involved in modulating signal transduction pathways and transcription mediated by various factors, notably CREB that requires the recruitment of the co-activators CREB-binding protein (CBP)/p300. Here we investigated the role of HBx and its potential interaction with CBP/p300 in regulating CREB transcriptional activity. We show that HBx and CBP/p300 synergistically enhanced CREB activity and that CREB phosphorylation by protein kinase A was a prerequisite for the cooperative action of HBx and CBP/p300. We further show that HBx interacted directly with CBP/p300 in vitro and in vivo. Using chromatin immunoprecipitation, we provide evidence that HBx physically occupied the CREB-binding domain of CREB-responsive promoters of endogenous cellular genes such as interleukin 8 and proliferating cell nuclear antigen. Moreover expression of HBx increased the recruitment of p300 to the interleukin 8 and proliferating cell nuclear antigen promoters in cells, and this is associated with increased gene expression. As recruitment of CBP/p300 is known to represent the limiting event for activating CREB target genes, HBx may disrupt this cellular regulation, thus predisposing cells to transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158882     DOI: 10.1074/jbc.M606774200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 2.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 3.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

4.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

Authors:  Laura Belloni; Teresa Pollicino; Francesca De Nicola; Francesca Guerrieri; Giuseppina Raffa; Maurizio Fanciulli; Giovanni Raimondo; Massimo Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

5.  Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.

Authors:  Xu You Liu; Shao Hui Tang; Sheng Lan Wu; Yu Hong Luo; Ming Rong Cao; Hong Ke Zhou; Xiang Wu Jiang; Jian Chang Shu; Cai Qun Bie; Si Min Huang; Zhan Hong Zheng; Fei Gao
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

6.  Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.

Authors:  Lin Deng; Xiang Gan; Masahiko Ito; Ming Chen; Hussein H Aly; Chieko Matsui; Takayuki Abe; Koichi Watashi; Takaji Wakita; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura; Masashi Mizokami; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

7.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 8.  Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.

Authors:  Yi Tian; Weibing Yang; Jianxun Song; Yuzhang Wu; Bing Ni
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

9.  Syk inhibits the activity of protein kinase A by phosphorylating tyrosine 330 of the catalytic subunit.

Authors:  Shuai Yu; He Huang; Anton Iliuk; Wen-Horng Wang; Keerthi B Jayasundera; W Andy Tao; Carol B Post; Robert L Geahlen
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

10.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.